263 related articles for article (PubMed ID: 36310035)
21. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
Sucur A; Jajic Z; Artukovic M; Matijasevic MI; Anic B; Flegar D; Markotic A; Kelava T; Ivcevic S; Kovacic N; Katavic V; Grcevic D
Arthritis Res Ther; 2017 Jun; 19(1):142. PubMed ID: 28619088
[TBL] [Abstract][Full Text] [Related]
22. Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier.
Eugenin EA; Berman JW
Methods; 2003 Apr; 29(4):351-61. PubMed ID: 12725802
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.
Aviles H; Stiles J; O'Donnell P; Orshal J; Leid J; Sonnenfeld G; Monroy F
J Parasitol; 2008 Dec; 94(6):1282-8. PubMed ID: 19127964
[TBL] [Abstract][Full Text] [Related]
24. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.
Mahad D; Callahan MK; Williams KA; Ubogu EE; Kivisäkk P; Tucky B; Kidd G; Kingsbury GA; Chang A; Fox RJ; Mack M; Sniderman MB; Ravid R; Staugaitis SM; Stins MF; Ransohoff RM
Brain; 2006 Jan; 129(Pt 1):212-23. PubMed ID: 16230319
[TBL] [Abstract][Full Text] [Related]
25. The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
Pevida M; Lastra A; Meana Á; Hidalgo A; Baamonde A; Menéndez L
Neuroscience; 2014 Feb; 259():113-25. PubMed ID: 24316469
[TBL] [Abstract][Full Text] [Related]
26. Role Of The C-C Motif Chemokine Ligand 5 (CCL5) And Its Receptor, C-C Motif Chemokine Receptor 5 (CCR5) In The Genesis Of Aldosterone-induced Hypertension, Vascular Dysfunction, And End-organ Damage.
Costa RM; Cerqueira DM; Bruder-Nascimento A; Alves JV; Awata WAC; Singh S; Kufner A; Cifuentes-Pagano E; Pagano PJ; Ho J; Bruder-Nascimento T
bioRxiv; 2023 Sep; ():. PubMed ID: 37790434
[TBL] [Abstract][Full Text] [Related]
27. Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients Control CCL4 and CXCL10 Levels in a Human Blood Brain Barrier Model.
Verite J; Janet T; Julian A; Chassaing D; Page G; Paccalin M
Curr Alzheimer Res; 2017; 14(11):1215-1228. PubMed ID: 28413983
[TBL] [Abstract][Full Text] [Related]
28. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.
Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM
Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609
[TBL] [Abstract][Full Text] [Related]
29. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
[TBL] [Abstract][Full Text] [Related]
30. Redirection of doublecortin-positive cell migration by over-expression of the chemokines MCP-1, MIP-1α and GRO-α in the adult rat brain.
Tang SK; Knobloch RA; Maucksch C; Connor B
Neuroscience; 2014 Feb; 260():240-8. PubMed ID: 24361178
[TBL] [Abstract][Full Text] [Related]
31. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
32. Met-RANTES preserves the blood-brain barrier through inhibiting CCR1/SRC/Rac1 pathway after intracerebral hemorrhage in mice.
Yan J; Xu W; Lenahan C; Huang L; Ocak U; Wen J; Li G; He W; Le C; Zhang JH; Mo L; Tang J
Fluids Barriers CNS; 2022 Jan; 19(1):7. PubMed ID: 35062973
[TBL] [Abstract][Full Text] [Related]
33. Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains.
van Gemst JJ; Kouwenberg M; Rops ALWMM; van Kuppevelt TH; Berden JH; Rabelink TJ; Loeven MA; van der Vlag J
PLoS One; 2018; 13(9):e0201560. PubMed ID: 30248108
[TBL] [Abstract][Full Text] [Related]
34. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy.
Louboutin JP; Strayer DS
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524
[TBL] [Abstract][Full Text] [Related]
35. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
[TBL] [Abstract][Full Text] [Related]
36. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
[TBL] [Abstract][Full Text] [Related]
37. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
Soria G; Ben-Baruch A
Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
[TBL] [Abstract][Full Text] [Related]
38. RANTES and MCP-3 antagonists bind multiple chemokine receptors.
Gong JH; Uguccioni M; Dewald B; Baggiolini M; Clark-Lewis I
J Biol Chem; 1996 May; 271(18):10521-7. PubMed ID: 8631850
[TBL] [Abstract][Full Text] [Related]
39. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels.
Andjelkovic AV; Pachter JS
J Neurochem; 2000 Nov; 75(5):1898-906. PubMed ID: 11032879
[TBL] [Abstract][Full Text] [Related]
40. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
Sarau HM; Rush JA; Foley JJ; Brawner ME; Schmidt DB; White JR; Barnette MS
J Pharmacol Exp Ther; 1997 Oct; 283(1):411-8. PubMed ID: 9336350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
